Dr Foldi’s research priority is to understand the neurobiological mechanisms that underlie serious psychiatric disease. She is particularly interested in the often-unreported response heterogeneity that occurs in single neurons, animal models and patients in the clinic. She believes that interrogating the mechanisms underpinning this variability will inform the development of more effective treatment strategies.
Claire's current work focuses on the impact of specific neural circuitries on feeding behaviour and body weight maintenance in anorexia nervosa and the therapeutic potential of psilocybin for treating anorectic pathologies. The Foldi Lab is funded by the National Health and Medical Research Council (NHMRC) of Australia, with previous funding from the Rebecca L Cooper Medical Research Foundation and the British Society for Neuroendocrinology.
